2nd Quarter - Report

NVG, LLC for PFIZER INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property, data exclusivity and patent eligibility, generally; CREATES Act of 2019 (S.340)/(H.R.965); Preserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); Affordable Prescriptions for Patients Act (S.1416); Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3991); Affordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398); Protecting Consumer Access to Generic Drugs Act (H.R. 1499).

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1224 (116th), H.R. 2374 (116th), H.R. 1499 (116th), H.R. 3991 (116th), H.R. 4398 (116th), H.R. 2375 (116th), S. 64 (116th), S. 1416 (116th), H.R. 965 (116th), S. 340 (116th)

Budget/Appropriations BUD

Issues related to drug supply chain shortages, childhood vaccination coverage disparities under Medicaid and CHIP and shared clinical decision-making for vaccines in the Senate FY 2021 LHHS Appropriations bill and in H.R. 7614, House Fiscal Year Labor, Health and Human Services Appropriations bill.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —
ANDREA LARUE —
JANE LOEWENSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7614 (116th)

Health Issues HCR

Prescription drug coverage and payment policies; S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act; Medical innovation issues.

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE —
EDEN SHIFERAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5076 (116th), S. 1872 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.